Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 14.46 Billion

CAGR (2026-2031)

7.56%

Fastest Growing Segment

Aflatoxin

Largest Market

Europe

Market Size (2031)

USD 22.39 Billion

Market Overview

The Global Mycotoxin Testing Market will grow from USD 14.46 Billion in 2025 to USD 22.39 Billion by 2031 at a 7.56% CAGR. Mycotoxin testing comprises the analytical protocols employed to detect and quantify toxic secondary metabolites produced by fungi in agricultural commodities and processed foods. The global market is primarily propelled by the enforcement of stringent international food safety regulations and the expanding volume of global trade which necessitates rigorous compliance with maximum residue limits. Additionally the increasing prevalence of fungal contamination due to erratic climate patterns serves as a fundamental driver for the adoption of routine testing protocols.

Despite the robust demand the high capital investment required for advanced chromatographic instruments and the complexity of sample preparation present significant barriers to market expansion in developing regions. Accurate data remains pivotal for risk management. According to the Alert and Cooperation Network 2023 Annual Report published in 2024 mycotoxins persisted as a major safety issue ranking as the third most notified hazard category with 401 notifications recorded across the European network.

Key Market Drivers

Escalating impact of climate change on crop susceptibility to mold acts as a paramount driver for the Global Mycotoxin Testing Market. Extreme weather patterns, ranging from prolonged droughts to excessive rainfall, create optimal environments for fungal proliferation in agricultural commodities, necessitating more frequent and comprehensive analysis. As supply chains face heightened contamination risks, the industry relies on data to predict and manage these biological hazards. According to dsm-firmenich, March 2025, in the 'World Mycotoxin Survey', all six main mycotoxins increased in occurrence compared to the previous year, with risk levels classified as extreme in regions such as North America and South Asia. This rising prevalence forces producers to adopt stringent screening to ensure raw materials remain viable for processing and consumption.

The growing demand for high-quality animal feed and the critical need to mitigate economic losses from post-harvest contamination further stimulate market adoption. Mycotoxin co-occurrence—where multiple toxins exist simultaneously—poses severe health risks to livestock, driving the shift toward advanced multi-toxin detection methods to preserve herd productivity and profitability. According to Cargill, March 2025, in the 'World Mycotoxin Report' findings presented at the World Mycotoxin Forum, co-occurrence remains a major challenge, with 78% of tested feed samples containing three or more mycotoxins. This operational necessity translates into significant financial performance for testing providers; according to Neogen Corporation, in 2025, the Food Safety segment accounted for 71.3% of the company's total annual revenues, underscoring the sector's robust commercial expansion.

Download Free Sample Report

Key Market Challenges

The high capital investment required for advanced chromatographic instruments constitutes a significant structural impediment to the broader expansion of the global mycotoxin testing market. State-of-the-art detection systems, such as liquid chromatography-mass spectrometry, are essential for achieving the sensitivity needed to identify trace contamination levels. However, the exorbitant procurement and operational costs associated with this technology create a high entry barrier for small-scale laboratories and food processors, particularly in developing economies. This financial burden limits the adoption of automated testing protocols to well-funded organizations in industrialized nations, effectively stifling demand in emerging markets where the risk of fungal contamination is often highest.

Furthermore, the complexity of sample preparation demands specialized infrastructure and highly skilled personnel, which adds to the operational expenditure. This technical exclusivity prevents smaller agricultural entities from implementing routine internal testing, forcing them to rely on third-party services or forgo testing entirely. The necessity for such rigorous, high-cost testing is evident in trade compliance data. According to the U.S. Grains Council, in 2024, the Corn Harvest Quality Report indicated that 98.9% of tested samples met the strict federal action levels for aflatoxin. Verifying compliance at such precise thresholds requires sophisticated instrumentation that remains financially inaccessible to many market participants, thereby capping the total addressable market for testing solutions.

Key Market Trends

The increased surveillance of emerging and masked mycotoxins is fundamentally reshaping analytical strategies within the market. Regulatory bodies and industry players are expanding testing panels beyond traditional regulated compounds to detect modified forms and lesser-known fungal metabolites that standard screening often misses. This shift is driven by the need to understand the full toxicological burden of feed and food matrices, particularly as non-regulated toxins become more prevalent. According to Patent Co, February 2025, in the '2024 Harvest Survey', 100% of corn samples analyzed from multiple European nations were contaminated with more than one mycotoxin type, with emerging toxins such as beauvericin identified as primary contaminants alongside regulated compounds.

Concurrently, the digitalization of testing data and traceability is emerging as a critical trend to manage the complexity of supply chain safety. Laboratories and food processors are increasingly integrating artificial intelligence and cloud-based platforms to aggregate testing results, predict contamination risks, and ensure real-time regulatory compliance. This technological transition moves the industry from reactive testing to proactive risk intelligence, allowing for faster decision-making during outbreaks. According to SGS, February 2025, in its 'Digicomply' risk intelligence insights, mycotoxins persisted as one of the top three reported food safety hazards globally over the preceding 24 months, underscoring the reliance on digital tools to monitor these biological threats.

Segmental Insights

The Aflatoxin segment is currently recognized as the fastest-growing category within the Global Mycotoxin Testing Market, driven primarily by stringent international regulatory frameworks. Major authorities, such as the United States Food and Drug Administration and the European Food Safety Authority, enforce rigorous maximum residue limits for these toxins in staple agricultural commodities like maize and groundnuts. Consequently, producers and exporters must adopt frequent screening protocols to ensure compliance with these established safety standards and facilitate cross-border trade, directly fueling the rapid expansion of aflatoxin testing activities globally.

Regional Insights

Europe maintains a dominant position in the global mycotoxin testing market due to the enforcement of stringent regulatory standards regarding food safety. The European Commission and the European Food Safety Authority have established rigorous maximum levels for contaminants in food and animal feed, which necessitates frequent and comprehensive analysis by producers. This strict framework compels manufacturers and importers to implement regular testing protocols to ensure compliance and secure market access. Additionally, high public awareness regarding food quality drives the consistent demand for effective detection services across the region.

Recent Developments

  • In February 2025, dsm-firmenich released the comprehensive results of its World Mycotoxin Survey, which analyzed over 28,000 feed samples collected from 95 countries throughout the previous year. The findings revealed a significant increase in the prevalence of all six major mycotoxins compared to 2023, with risks intensifying in regions such as Central Europe, the Middle East, and North Africa. The report highlighted the growing challenge of co-occurrence, where multiple toxins are present simultaneously, and underscored the necessity for robust testing protocols to safeguard animal health and feed quality globally.
  • In January 2025, Alltech announced a strategic expansion of its mycotoxin management program through a new collaboration with Waters Corporation and its VICAM brand. This partnership integrated the analysis capabilities of the Vertu TOUCH lateral flow strip test reader with the Alltech RAPIREAD system, enabling the detection of up to six major mycotoxins in a single sample. The Global Technical Support Lead at Alltech noted that this development would allow producers to perform rapid, on-site testing for contaminants like aflatoxin and fumonisin, thereby enhancing risk assessment and decision-making in feed mills and farms.
  • In September 2024, VICAM was honored with the AgTech Breakthrough Innovation Award for its Ochra-V MAX, recognizing the product as the "Overall Food Quality Solution of the Year." This rapid quantitative test was acknowledged for its ability to deliver precise results for ochratoxin A in complex matrices like cocoa powder and roasted coffee in as little as 15 minutes. The award highlighted the company's success in revolutionizing mycotoxin detection by providing speed and accuracy comparable to traditional laboratory methods, thus enabling producers to make real-time quality management decisions.
  • In April 2024, Romer Labs secured official approval from the United States Department of Agriculture's Federal Grain Inspection Service (USDA-FGIS) for its AgraStrip Pro Ochratoxin A WATEX test kit. This certification validated the efficacy of the test for the quantitative determination of ochratoxin A in wheat, confirming its accuracy and reliability for industrial use. The approval marked a significant milestone for the company's water-based extraction technology, which eliminates the need for organic solvents, offering a safer and more sustainable solution for rapid on-site mycotoxin screening in the grain industry.

Key Market Players

  • SGS Société Générale de Surveillance SA.
  • Bureau Veritas
  • Eurofins Scientific
  • Intertek Group plc
  • Mérieux NutriSciences Corporation
  • ALS Limited
  • Neogen Corporation
  • AsureQuality Limited.
  • Charm Sciences, Inc.
  • Premier Analytical Services

By Type

By Technology

By Sample

By End User

By Region

  • Aflatoxin
  • Deoxynivalenol
  • Ochratoxins
  • Fumonisins
  • Others
  • HPLC-based
  • LC-MS/MS-based
  • Immunoassay-based
  • Others
  • Food
  • Feed
  • Research Lab
  • Research Institutes
  • Food Testing Industries
  • Feed Testing Industries
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Mycotoxin Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Mycotoxin Testing Market, By Type:
  • Aflatoxin
  • Deoxynivalenol
  • Ochratoxins
  • Fumonisins
  • Others
  • Mycotoxin Testing Market, By Technology:
  • HPLC-based
  • LC-MS/MS-based
  • Immunoassay-based
  • Others
  • Mycotoxin Testing Market, By Sample:
  • Food
  • Feed
  • Mycotoxin Testing Market, By End User:
  • Research Lab
  • Research Institutes
  • Food Testing Industries
  • Feed Testing Industries
  • Others
  • Mycotoxin Testing Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mycotoxin Testing Market.

Available Customizations:

Global Mycotoxin Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Mycotoxin Testing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Mycotoxin Testing Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Type (Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, Others)

5.2.2.  By Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Others)

5.2.3.  By Sample (Food, Feed)

5.2.4.  By End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries, Others)

5.2.5.  By Region

5.2.6.  By Company (2025)

5.3.  Market Map

6.    North America Mycotoxin Testing Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Type

6.2.2.  By Technology

6.2.3.  By Sample

6.2.4.  By End User

6.2.5.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Mycotoxin Testing Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Type

6.3.1.2.2.  By Technology

6.3.1.2.3.  By Sample

6.3.1.2.4.  By End User

6.3.2.    Canada Mycotoxin Testing Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Type

6.3.2.2.2.  By Technology

6.3.2.2.3.  By Sample

6.3.2.2.4.  By End User

6.3.3.    Mexico Mycotoxin Testing Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Type

6.3.3.2.2.  By Technology

6.3.3.2.3.  By Sample

6.3.3.2.4.  By End User

7.    Europe Mycotoxin Testing Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Type

7.2.2.  By Technology

7.2.3.  By Sample

7.2.4.  By End User

7.2.5.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Mycotoxin Testing Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Type

7.3.1.2.2.  By Technology

7.3.1.2.3.  By Sample

7.3.1.2.4.  By End User

7.3.2.    France Mycotoxin Testing Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Type

7.3.2.2.2.  By Technology

7.3.2.2.3.  By Sample

7.3.2.2.4.  By End User

7.3.3.    United Kingdom Mycotoxin Testing Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Type

7.3.3.2.2.  By Technology

7.3.3.2.3.  By Sample

7.3.3.2.4.  By End User

7.3.4.    Italy Mycotoxin Testing Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Type

7.3.4.2.2.  By Technology

7.3.4.2.3.  By Sample

7.3.4.2.4.  By End User

7.3.5.    Spain Mycotoxin Testing Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Type

7.3.5.2.2.  By Technology

7.3.5.2.3.  By Sample

7.3.5.2.4.  By End User

8.    Asia Pacific Mycotoxin Testing Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Type

8.2.2.  By Technology

8.2.3.  By Sample

8.2.4.  By End User

8.2.5.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Mycotoxin Testing Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Type

8.3.1.2.2.  By Technology

8.3.1.2.3.  By Sample

8.3.1.2.4.  By End User

8.3.2.    India Mycotoxin Testing Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Type

8.3.2.2.2.  By Technology

8.3.2.2.3.  By Sample

8.3.2.2.4.  By End User

8.3.3.    Japan Mycotoxin Testing Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Type

8.3.3.2.2.  By Technology

8.3.3.2.3.  By Sample

8.3.3.2.4.  By End User

8.3.4.    South Korea Mycotoxin Testing Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Type

8.3.4.2.2.  By Technology

8.3.4.2.3.  By Sample

8.3.4.2.4.  By End User

8.3.5.    Australia Mycotoxin Testing Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Type

8.3.5.2.2.  By Technology

8.3.5.2.3.  By Sample

8.3.5.2.4.  By End User

9.    Middle East & Africa Mycotoxin Testing Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Type

9.2.2.  By Technology

9.2.3.  By Sample

9.2.4.  By End User

9.2.5.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Mycotoxin Testing Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Type

9.3.1.2.2.  By Technology

9.3.1.2.3.  By Sample

9.3.1.2.4.  By End User

9.3.2.    UAE Mycotoxin Testing Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Type

9.3.2.2.2.  By Technology

9.3.2.2.3.  By Sample

9.3.2.2.4.  By End User

9.3.3.    South Africa Mycotoxin Testing Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Type

9.3.3.2.2.  By Technology

9.3.3.2.3.  By Sample

9.3.3.2.4.  By End User

10.    South America Mycotoxin Testing Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Technology

10.2.3.  By Sample

10.2.4.  By End User

10.2.5.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Mycotoxin Testing Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Type

10.3.1.2.2.  By Technology

10.3.1.2.3.  By Sample

10.3.1.2.4.  By End User

10.3.2.    Colombia Mycotoxin Testing Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Type

10.3.2.2.2.  By Technology

10.3.2.2.3.  By Sample

10.3.2.2.4.  By End User

10.3.3.    Argentina Mycotoxin Testing Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Type

10.3.3.2.2.  By Technology

10.3.3.2.3.  By Sample

10.3.3.2.4.  By End User

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Mycotoxin Testing Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  SGS Société Générale de Surveillance SA.

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Bureau Veritas

15.3.  Eurofins Scientific

15.4.  Intertek Group plc

15.5.  Mérieux NutriSciences Corporation

15.6.  ALS Limited

15.7.  Neogen Corporation

15.8.  AsureQuality Limited.

15.9.  Charm Sciences, Inc.

15.10.  Premier Analytical Services

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Mycotoxin Testing Market was estimated to be USD 14.46 Billion in 2025.

Europe is the dominating region in the Global Mycotoxin Testing Market.

Aflatoxin segment is the fastest growing segment in the Global Mycotoxin Testing Market.

The Global Mycotoxin Testing Market is expected to grow at 7.56% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.